Загрузка...
Drug development research for novel adiponectin receptor-targeted antidiabetic drugs contributing to healthy longevity
It is well recognized that the decrease of adiponectin associated with high-fat diet and lack of exercise accounts for the onset of insulin resistance, type 2 diabetes, the metabolic syndrome, and cardiovascular disease. Our research efforts have led to the identification of adiponectin receptors, A...
Сохранить в:
| Опубликовано в: : | Diabetol Int |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Japan
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6763548/ https://ncbi.nlm.nih.gov/pubmed/31592400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13340-019-00409-6 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|